Nurix Therapeutics Inc (NRIX)

Deferred Revenue

$8.61M

Quarterly · Period ending: · USD

NRIX logo

NRIX Deferred Revenue

Latest reported$8.61M
NRIX Quarterly Deferred Revenue ($0.00 → $8.61M)
High-resolution chart · PNG

NRIX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nurix Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
8,610,000
13,324,000
18,754,000
17,580,000
25,993,000
27,420,000
30,591,000
38,364,000
47,997,000
46,769,000
46,077,000
48,098,000
32,037,000
44,063,000
38,305,000
37,633,000
36,342,000
41,319,000
43,186,000
41,212,000
35,250,000
33,761,000
32,751,000
32,799,000
30,299,000
25,372,000
21,395,000
9,612,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.